Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2009
12/10/2009CA2726270A1 Small molecule leptin receptor modulators
12/10/2009CA2725573A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof
12/10/2009CA2725572A1 Heterocyclic urea derivatives and methods of use thereof
12/10/2009CA2725316A1 Novel isoxazole derivative
12/09/2009EP2130828A1 Sulfonamide derivative
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/09/2009EP1991529B1 Substituted arylsulfonamides as antiviral agents
12/09/2009EP1745040B1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/09/2009EP1648886B1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
12/09/2009EP1435964B1 Novel prodrugs of n-h bond-containing compounds and methods of making thereof
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1067109B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/09/2009CN101600712A Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/09/2009CN101600706A Akt活性抑制剂 Akt activity inhibitor
12/09/2009CN101600700A Novel 2-aminooxazolines as TAAR1 ligands for CNS disorders
12/09/2009CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
12/09/2009CN101597283A Triazolyl oxazolidinone compounds and antibiosis application thereof
12/09/2009CN101597282A Substituted diketopiperazines and their use as oxytocyn antagonists
12/09/2009CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009CN100567266C Cannabinoid receptor ligands
12/08/2009US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629463 Pesticides that are more effective, less costly, less toxic, environmentally safer; 1-(2-chloromethyl-N-[2-methyl-6-(1-methyl-1H-imidazol-2-yl)phenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide
12/08/2009US7629460 Dihydropteridione derivatives, process for their manufacture and their use as medicament
12/08/2009US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629348 Insecticides; for human or veterinary medicine
12/08/2009US7629339 inhibitors of protein kinases and are useful in treating cancer; 4-({5-[5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl}-amino)-3-methoxy-butyric acid; anticarcinogenic agent
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009CA2422807C N-substituted benzothiophenesulfonamide derivatives
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2415486C Pyramidine derivatives
12/08/2009CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2355075C Heteroaryl-cyclic acetals
12/08/2009CA2340952C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
12/08/2009CA2315113C Pyridones as src family sh2 domain inhibitors
12/03/2009WO2009146112A1 Compositions and methods for inhibiting sphingosine kinase
12/03/2009WO2009145899A1 5-substituted isoindoline compounds
12/03/2009WO2009145856A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009WO2009145718A1 Isoindoline derivatives comprising an additional heterocyclic group and their use in the treatment of pain disorders
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009143992A1 2-alkoxy-substituted dicyanopyridines and use thereof
12/03/2009WO2009143571A1 Antiviral salts
12/03/2009WO2009122034A3 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/03/2009WO2009115572A3 Novel heterocyclic compounds and uses therof
12/03/2009WO2009106599A3 Substituted piperidines as therapeutic compounds
12/03/2009WO2009057079A3 Novel pyrimidine derivatives
12/03/2009US20090299063 Inhibitors for Extracellular Signal-Regulated Kinase Docking Domains and Uses Therefor
12/03/2009US20090299062 Thermosetting compound, composition containing the same, and molded article
12/03/2009US20090299059 Novel Compound Having Heterocyclic Ring
12/03/2009US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009US20090298897 Treatment of Inflammatory Disorders With Triazole Compounds
12/03/2009US20090298885 Methylene urea derivatives
12/03/2009US20090298871 Sulfonyl-phenyl-2h-[1,2,4]oxadiazol-5-one derivatives , processes for their preparation and their use as pharmaceuticals
12/03/2009US20090298854 Indole acetic acid derivatives and their use as pharmaceutical agents
12/03/2009US20090298833 Piperidinyl derivatives as modulators of chemokine receptor activity
12/03/2009US20090298831 Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
12/03/2009US20090298830 4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use
12/03/2009US20090298829 Melanocortin receptor agonists
12/03/2009US20090298827 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298826 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
12/03/2009US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
12/03/2009US20090298824 Organic compounds
12/03/2009US20090298823 Inhibitors of protein kinases
12/03/2009US20090298821 Hydroxy and alkoxy substituted ih-imidazonaphthyridines and methods
12/03/2009US20090298811 Benzimidazolone derivatives
12/03/2009US20090298806 Factor xa inhibitors
12/03/2009US20090297476 Novel peptide inhibitors of hepatitis c virus replication
12/03/2009CA2725897A1 Novel substituted pyrazoles, 1,2,4-oxadiazoles, and 1,3,4-oxadiazoles
12/03/2009CA2725618A1 Antiviral salts
12/03/2009CA2725603A1 5-substituted isoindoline compounds
12/03/2009CA2723205A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/03/2009CA2721065A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/02/2009EP2128158A1 Heterocyclic cyclopropyl-substituted FXR binding compounds
12/02/2009EP2128157A1 Heterocyclidene-n-(aryl)acetamide derivative
12/02/2009EP2128156A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity
12/02/2009EP2128138A1 Pyrazole compound
12/02/2009EP2128136A1 2-phenylnicotinic acid derivative
12/02/2009EP2128124A1 Novel hexatriene- -carbonyl compound
12/02/2009EP2125797A1 Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
12/02/2009EP2125777A1 Spiro substituted compounds as angiogenesis inhibitors
12/02/2009EP1902046B1 Piperidine derivatives useful as histamine h3 antagonists
12/02/2009EP1896453B1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
12/02/2009EP1863785B1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions
12/02/2009EP1799657B1 Isoxazoline derivatives and their use as herbicides
12/02/2009EP1664029B1 Quinazoline derivatives as antitumor agents
12/02/2009EP1542684B1 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
12/02/2009EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009CN101595105A 2-substituted 5-membered heterocycles as SCD inhibitors
12/02/2009CN101595103A Pyrimidine derivatives
12/02/2009CN101595102A Biaryl ether urea compounds
12/02/2009CN101595101A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/02/2009CN101595093A Organic compounds
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 647